TP53 and B-cell chronic lymphocytic leukemia: For this purpose, the TP53 Network of the European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) had released a first recommendation in 2012 and updated it recently to take into account the emergence of NGS (73, 74).